SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

10 Jan 2019 07:00

RNS Number : 6695M
McBride PLC
10 January 2019
 

10 January 2019

 

McBride plc

 

Trading Update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, today provides a trading update for the six months ended 31 December 2018.

 

The Group's first half continuing revenues at constant currency were 10.8% higher than the prior year. Excluding the benefit of first quarter revenues from Danlind, continuing underlying revenues were 6.0% higher. Underlying Household division sales were 5.9% higher, primarily as a result of higher sales in the East and UK regions (up 23.4% and 10.5% respectively).

 

As outlined in our recent AGM trading update, the first half year has seen raw material, packaging and logistics costs higher than anticipated, particularly in the second quarter. These have been partly mitigated by improved sales volumes and lower overheads. The pricing outlook for many of our key raw materials has improved recently and in the absence of this reversing significantly, the Board expects full year earnings to be in line with expectations, with full year profit delivery weighted to the second half.

The sale of the European Personal Care Liquids business was successfully completed during the second quarter and we continue to progress plans for the closure of our UK Aerosols factory in the second half year as expected. The integration of Danlind continued with our Danish factories transitioning onto the McBride ERP system in December.

 

The Group will announce its interim results for the six months ended 31 December 2018 on 21 February.

 

Rik De Vos, Chief Executive said;

 

"The Group has made significant strategic progress in the first half of this financial year completing the sale of Personal Care Liquids, integrating Danlind onto the McBride systems and managing our revenue growth. Margins remain our key focus at present and the recent improvement in the pricing outlook for raw materials following almost two years of significant inflation will see some recovery of the cumulative cost impact to the business. I remain confident that the Group continues to be well positioned to exploit the growth and margin opportunities in the remainder of this financial year and beyond."

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQKLFBKFFLBBV
Date   Source Headline
7th Feb 20087:01 amRNSInterim Results
30th Jan 20085:15 pmRNSTotal Voting Rights-Amend
30th Jan 20082:17 pmRNSTotal Voting Rights
29th Jan 20083:37 pmRNSHolding(s) in Company
29th Jan 200811:47 amRNSHolding(s) in Company
28th Jan 200810:19 amRNSHolding(s) in Company
20th Dec 20074:49 pmRNSHolding(s) in Company
20th Dec 200712:50 pmRNSDirector/PDMR Shareholding
20th Dec 20077:04 amRNSTrading Statement
18th Dec 20072:15 pmRNSHolding(s) in Company
13th Dec 20079:58 amRNSDirector/PDMR Shareholding
12th Dec 200711:42 amRNSDirector/PDMR Shareholding
6th Dec 200711:19 amRNSHolding(s) in Company
5th Dec 20079:20 amRNSHolding(s) in Company
30th Nov 20079:29 amRNSTotal Voting Rights
16th Nov 20073:06 pmRNSDirector/PDMR Shareholding
15th Nov 200712:36 pmRNSDirector/PDMR Shareholding
14th Nov 20072:31 pmRNSDirector/PDMR Shareholding
12th Nov 200710:10 amRNSResult of AGM
8th Nov 20075:54 pmRNSHolding(s) in Company
8th Nov 20074:23 pmRNSHolding(s) in Company
5th Nov 20075:02 pmRNSHolding(s) in Company
31st Oct 20072:22 pmRNSTotal Voting Rights
30th Oct 20074:37 pmRNSHolding(s) in Company
30th Oct 20077:01 amRNSInterim Management Statement
29th Oct 20071:45 pmRNSBlocklisting Interim Review
29th Oct 20071:41 pmRNSBlocklisting Interim Review
18th Oct 20076:27 pmRNSHolding(s) in Company
16th Oct 20072:23 pmRNSTransaction in Own Shares
10th Oct 20073:45 pmRNSDirector/PDMR Shareholding
9th Oct 20077:01 amRNSTransaction in Own Shares
4th Oct 200710:44 amRNSAnnual Information Update
28th Sep 20073:52 pmRNSTotal Voting Rights
28th Sep 20073:11 pmRNSTransaction in Own Shares
27th Sep 200712:30 pmRNSAnnual Report and Accounts
25th Sep 20073:23 pmRNSTransaction in Own Shares
19th Sep 200711:50 amRNSHolding(s) in Company
19th Sep 200711:12 amRNSHolding(s) in Company
17th Sep 200712:31 pmRNSHolding(s) in Company
6th Sep 20077:02 amRNSPreliminary Results
4th Sep 20072:56 pmRNSHolding(s) in Company
30th Aug 20072:10 pmRNSTotal Voting Rights
16th Aug 200711:43 amRNSHolding(s) in Company
16th Aug 20079:27 amRNSDirector/PDMR Shareholding
14th Aug 20073:09 pmRNSHolding in Company-Replace
14th Aug 20071:04 pmRNSHolding(s) in Company
9th Aug 200712:10 pmRNSHolding(s) in Company
9th Aug 200711:28 amRNSDirector/PDMR Shareholding
2nd Aug 200710:45 amRNSDirector/PDMR Shareholding
30th Jul 20073:08 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.